SCHEMBL6926504

SCHEMBL6926504

N#CCOc1c(Cl)ccc2c1c1ccccc1n2Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.48
P2RX4 Q99571 1/20 0.43
CCR2 P41597 3/20 0.40
UTS2R Q9UKP6 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPT P10636 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
TP53 P04637 1/20 0.37
PDE9A O76083 1/20 0.37
PDE1C Q14123 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
TDP1 Q9NUW8 3/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919987 0.81 CYP19A1 (0.49) CYP19A1P2RX4CCR2UTS2RALDH1A1
Acetonitrile SCHEMBL27465807 0.75 CYP19A1 (0.50) CYP19A1P2RX4CCR2UTS2RALDH1A1
SCHEMBL27482466 0.73 CYP19A1 (0.59) CYP19A1P2RX4CCR2UTS2RALDH1A1
SCHEMBL6925221 0.73 CYP19A1 (0.59) CYP19A1P2RX4CCR2UTS2RALDH1A1
SCHEMBL6923666 0.72 KMT2A (0.44) CYP19A1P2RX4ALDH1A1MAPTTSHR
SCHEMBL6921062 0.71 MAPT (0.39) CYP19A1P2RX4ALDH1A1MAPTTSHR
SCHEMBL6924426 0.71 TSHR (0.47) P2RX4MAPTTSHRSMN1; SMN2KMT2A
SCHEMBL8920050 0.69 CYP19A1 (0.61) CYP19A1P2RX4UTS2RALDH1A1KDM4E
SCHEMBL17439171 0.69 CYP19A1 (0.70) CYP19A1P2RX4ALDH1A1KDM4EMAPT
SCHEMBL30234033 0.69 CYP19A1 (0.70) CYP19A1P2RX4ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed